GSK 6-K 2025 - Equibles

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

Form 6-K

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

For the month of November 2025

Commission File Number 001-15170

GSK plc

(Translation of registrant's name into English)

79 New Oxford Street, London, WC1A 1DG

(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

Form 20-F . . . .X. . . . Form 40-F . . . . . . . .

GSK plc

GSK publishes provisional dividend dates

GSK announces the following dividend dates for 2026:

These dates are indicative and may be subject to change.

Results	Announcement date	Ordinary Shares Ex-dividend date	American Depositary Shares Ex-dividend date	Record date	Last date for DRIP elections	Payable
Q1 2026	Wednesday<br>29 April 2026	Thursday<br>14 May 2026	Friday<br>15 May 2026	Friday<br>15 May 2026	Thursday<br>18 June 2026	Thursday<br>9 July 2026
Q2 2026	Wednesday<br>29 July 2026	Thursday<br>13 August 2026	Friday<br>14 August 2026	Friday<br>14 August 2026	Thursday<br>17 September 2026	Thursday<br>8 October 2026
Q3 2026	Wednesday<br>28 October 2026	Thursday<br>12 November 2026	Friday<br>13 November 2026	Friday<br>13 November 2026	Monday<br>14 December 2026	Thursday<br>7 January 2027
Q4 2026	Wednesday<br>3 February 2027	Thursday<br>18 February 2027	Friday<br>19 February 2027	Friday<br>19 February 2027	Tuesday<br>16 March 2027	Thursday<br>8 April 2027

V A Whyte

Company Secretary

10 November 2025

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorised.

	GSK plc
	(Registrant)
Date: November<br>10, 2025
	By:/s/ VICTORIA<br>WHYTE<br><br><br>--------------------------
	Victoria Whyte
	Authorised<br>Signatory for and on
	behalf<br>of GSK plc